153 related articles for article (PubMed ID: 31019701)
41. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S
Am J Gastroenterol; 2017 Apr; 112(4):537-554. PubMed ID: 28139655
[TBL] [Abstract][Full Text] [Related]
42. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
43. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
Okabayashi T; Nishimori I; Maeda H; Hanazaki K
J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
[No Abstract] [Full Text] [Related]
44. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
45. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
46. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
Siegel A; Friedman M; Feldman D; Krishnan K; Casey B; Pisuchpen N; Kambadakone A; Chung DC
Pancreatology; 2022 Nov; 22(7):951-958. PubMed ID: 35995658
[TBL] [Abstract][Full Text] [Related]
47. Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers.
Frič P; Škrha J; Šedo A; Zima T; Bušek P; Kmochová K; Laclav M; Bunganič B; Solař S; Hrabal P; Bělina F; Záruba P; Škrha P; Zavoral M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):e33-e43. PubMed ID: 27769077
[TBL] [Abstract][Full Text] [Related]
48. The role of PET scanning in pancreatic cancer.
Serrano OK; Chaudhry MA; Leach SD
Adv Surg; 2010; 44():313-25. PubMed ID: 20919529
[TBL] [Abstract][Full Text] [Related]
49. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
50. The Role of Computed Tomography and Magnetic Resonance Imaging in Accurate Size Estimation of Pancreatic Ductal Adenocarcinoma.
Alabousi M; Patlas MN
Can Assoc Radiol J; 2023 Aug; 74(3):478-479. PubMed ID: 36653945
[No Abstract] [Full Text] [Related]
51. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.
Farrell JJ
Gut Liver; 2015 Sep; 9(5):571-89. PubMed ID: 26343068
[TBL] [Abstract][Full Text] [Related]
52. Preoperative diagnosis of multiple intraductal tubulopapillary neoplasms of the pancreas: dynamic imaging features from endoscopic ultrasound.
Liu WH; Su XJ; Fang X; Jiang H; Guo SW; Wang KX
Endoscopy; 2021 Sep; 53(9):E345-E347. PubMed ID: 33175997
[No Abstract] [Full Text] [Related]
53. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
Tada M; Kawabe T; Arizumi M; Togawa O; Matsubara S; Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tateishi K; Isayama H; Toda N; Yoshida H; Omata M
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1265-70. PubMed ID: 16979953
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of pancreatic adenocarcinoma.
Simoes PK; Olson SH; Saldia A; Kurtz RC
Chin Clin Oncol; 2017 Jun; 6(3):24. PubMed ID: 28705001
[TBL] [Abstract][Full Text] [Related]
55. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study.
Hisada Y; Nagata N; Imbe K; Takasaki Y; Sekine K; Tajima T; Yanase M; Fujimoto K; Akiyama J; Uemura N
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):401-408. PubMed ID: 28512773
[TBL] [Abstract][Full Text] [Related]
56. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
[TBL] [Abstract][Full Text] [Related]
57. Intraductal papillary mucinous tumors of the pancreas.
Dumitrescu D; Popescu CF; Săftoiu A
Rom J Morphol Embryol; 2010; 51(3):447-53. PubMed ID: 20809019
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of a pancreatic cancer surveillance program from a psychological point of view.
Harinck F; Nagtegaal T; Kluijt I; Aalfs C; Smets E; Poley JW; Wagner A; van Hooft J; Fockens P; Bruno M; Bleiker EM
Genet Med; 2011 Dec; 13(12):1015-24. PubMed ID: 21857231
[TBL] [Abstract][Full Text] [Related]
59. SnapShot: pancreatic cancer.
Han H; Von Hoff DD
Cancer Cell; 2013 Mar; 23(3):424-424.e1. PubMed ID: 23518352
[No Abstract] [Full Text] [Related]
60. Which is the better strategy in patients with cystic pancreas lesions?
Felderbauer P; Bulut K
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):522; author reply 522. PubMed ID: 17445757
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
